Related Experiment Video
Updated: May 14, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Normal viability of Kai1/Cd82 deficient mice
John I Risinger1, Mary Custer, Lionel Feigenbaum
1Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University College of Human Medicine, Grand Rapids, Michigan; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
Molecular Carcinogenesis
|February 13, 2013
Summary
The KAI1/CD82 tetraspanin, a metastasis suppressor, showed no obvious defects in knockout mice. However, gene expression in male mouse cells revealed KAI1/CD82 influences cell division and proliferation.
Area of Science:
- Cell Biology
- Molecular Biology
- Genetics
Background:
- KAI1/CD82 is a tetraspanin protein involved in cell signaling.
- It functions as a metastasis suppressor gene, inhibiting cancer spread but not tumor formation.
Purpose of the Study:
- To investigate the in vivo functions of KAI1/CD82 by analyzing knockout mice.
- To explore the impact of KAI1/CD82 on cellular processes, particularly proliferation and adaptability.
Main Methods:
- Phenotypic characterization of KAI1/CD82 knockout, heterozygous, and wild-type mice.
- Analysis of viability, fertility, lymphocyte composition, blood chemistry, and histopathology.
- RNA sequencing of mouse embryo fibroblasts (MEFs) to compare gene expression profiles.
Main Results:
- KAI1/CD82 knockout mice exhibited no apparent defects in viability, fertility, or overall health.
- Gene expression analysis revealed significant sex-specific differences in transcript profiles between wild-type and KAI1/CD82 knockout MEFs.
- Male MEFs from knockout mice showed enrichment of genes related to cell division, suggesting KAI1/CD82 influences proliferation.
Conclusions:
- KAI1/CD82 does not appear essential for normal physiological processes in mice.
- KAI1/CD82 plays a role in regulating cell proliferation and division, particularly in male cells.
- These findings suggest KAI1/CD82 may impact adaptability to new environments, potentially influencing metastatic potential.
